This unique programme builds on the recent successes in clinical applications of immunotherapy for a range of immune-mediated diseases (for example, the use of anti-TNF therapies in rheumatoid arthritis patients) and, drawing on faculty-wide expertise, focuses on the processes involved in translating immunobiology research, using the eye as a model.
The processes involved in translating immunological discoveries into predictive, diagnostic and/or therapeutic applications are described in depth, using examples of successful translational studies to illustrate key aspects: the clinical question; study design and limitations. Students will also attend scientific lectures in relevant subject areas (immunology, molecular cell biology, pharmacology), gaining hands-on experience in an original research project.
Students undertake modules to the value of 180 credits.
The programme consists of five core modules (75 credits), three optional modules (45 credits), and a dissertation/report (60 credits).
Core modules: -Bioscience Research Skills -Masterclasses in Translational Immunobiology -Ocular Immunology -Research in Practice -Translating Science into the Clinic
Optional modules -Cost Benefit Analysis and Health -Genetics and Epidemiology of Ocular Disease -Modern Aspects of Drug Discovery -Ocular Cell Biology -Ocular Development in Health and Disease -Pharmacogenomics, Adverse Drug Reactions and Biomarkers
Dissertation/research project Students will carry out an independent research project supervised by internationally recognised researchers, resulting in a dissertation of 10,000–12,000 words and an oral presentation.
Teaching and learning The programme is delivered through a combination of lectures, seminars and student group presentations. Assessment is through a mixture of unseen examinations, coursework (essays, bioinformatic tasks, practicals), a major dissertation, and oral presentations.
The first cohort of students on the Applied Immunobiology MSc are due to graduate in 2016, therefore no information on graduate destinations is currently available.
Employability This programme is of particular interest to those science graduates considering alternative career directions in addition to mainstream research. Due to the translational content, this programme offers key knowledge and skills with wider applications outside of academia for those interested in pursuing clinical trial design, governance, clinical trial management, and grants administration within relevant governmental bodies, the pharmaceutical and medical industry.
Why study this degree at UCL?
UCL is the largest centre for biomedical research in the UK and offers unique opportunities to study applied immunobiology.
The UCL Institute of Ophthalmology is an international leader in translational research and clinical and industrial collaborations are in place. UCL academics who advise on the research methodology involved in successful translational projects – study design, applications for ethics approval, funding applications, peer-review publications, data presentation and writing skills – will provide case studies, presentations and seminars.
The eye is an excellent model for monitoring disease activity, responses to therapy, and clinical scoring, and is an ideal organ for delivering new therapies.
A medical degree or a minimum of an upper second-class UK Bachelor’s degree in biomedical science, or another relevant discipline, or an overseas qualification of an equivalent standard. If your education has not been conducted in the English language, you will be expected to demonstrate evidence of a good level of English proficiency.
Recipient: University College London
Insert previous message below for editing?
You haven’t included a message. Providing a specific message means universities will take your enquiry more seriously and helps them provide the information you need. Why not add a message here